Opaleye Management Inc. (GRCE) filed Form 4
- Filed on 2026-10-16
- Purchased 11,233 shares on 10/14/2026
- Purchased 23,485 shares on 10/15/2026
Opaleye Management Inc., reporting
GRCE
Grace Therapeutics, Inc. SEC filings
Every EDGAR filing for Grace Therapeutics, Inc. (GRCE), newest first, with AI summaries and stories.
- Ticker
- GRCE
- CIK
- 1444192
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Insider activity
- 10% owner bought $69K
- 10% owner bought $46K
- 10% owner bought $22K
Filings
4Grace Therapeutics, Inc.GRCELIVE 4Grace Therapeutics, Inc.GRCELIVE Opaleye Management Inc. filed Form 4
- Filed on 2026-10-13
- Purchased 2,077 shares on 2026-10-08
- Purchased 5,340 shares on 2026-10-09
Opaleye Management Inc., reporting
4Grace Therapeutics, Inc.GRCELIVE Grace Therapeutics, Inc. (GRCE) reports insider transactions.
- Opaleye Management Inc. bought 38,796 shares on 10/01/2026 at $2.0353.
- Opaleye Management Inc. bought 20,000 shares on 10/02/2026 at $2.0684.
- Opaleye Management Inc. bought 1,694 shares on 10/05/2026 at $2.06.
Opaleye Management Inc.
4/AGrace Therapeutics, Inc.GRCELIVE 2 insider filings
Opaleye Management Inc., insider filing for GRCE (amended)
Show all 2
- 4/AInsider filing for GRCE (amended)
- 4Insider filing for GRCE
Opaleye Management Inc.
4Grace Therapeutics, Inc.GRCELIVE Opaleye Management Inc., insider filing for GRCE
Opaleye Management Inc., reporting
4Grace Therapeutics, Inc.GRCELIVE 4 insider filings
Edward Neugeboren, insider filing for GRCE
Show all 4
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
Edward Neugeboren, reporting
8-KGrace Therapeutics, Inc.GRCELIVE 4Grace Therapeutics, Inc.GRCELIVE Opaleye Management Inc., insider filing for GRCE
Opaleye Management Inc., reporting
4Grace Therapeutics, Inc.GRCELIVE Prashant Kohli, insider filing for GRCE
Prashant Kohli, reporting
4Grace Therapeutics, Inc.GRCELIVE 4 insider filings
Robert J DelAversano, insider filing for GRCE
Show all 4
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
Robert J DelAversano, reporting
EFFECTGrace Therapeutics, Inc.GRCELIVE S-3Grace Therapeutics, Inc.GRCELIVE 4Grace Therapeutics, Inc.GRCELIVE Opaleye Management Inc., insider filing for GRCE
Opaleye Management Inc., reporting
SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE 2 13G filings
Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
ADAR1 Capital Management, LLC, filed by
8-KGrace Therapeutics, Inc.GRCELIVE 10-QGrace Therapeutics, Inc.GRCELIVE SCHEDULE 13GGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by Opaleye Management Inc.
Opaleye Management Inc., filed by
8-KGrace Therapeutics, Inc.GRCELIVE DEFA14AGrace Therapeutics, Inc.GRCELIVE DEF 14AGrace Therapeutics, Inc.GRCELIVE 8-KGrace Therapeutics, Inc.GRCELIVE 8-KGrace Therapeutics, Inc.GRCELIVE 8-KGrace Therapeutics, Inc.GRCELIVE 10-KGrace Therapeutics, Inc.GRCELIVE 8-KGrace Therapeutics, Inc.GRCELIVE SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
ADAR1 Capital Management, LLC, filed by
SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by Orin Hirschman (amended)
Orin Hirschman, filed by
8-KGrace Therapeutics, Inc.GRCELIVE 8-KGrace Therapeutics, Inc.GRCELIVE SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
ADAR1 Capital Management, LLC, filed by
SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by Nantahala Capital Management, LLC (amended)
Nantahala Capital Management, LLC, filed by
8-KGrace Therapeutics, Inc.GRCELIVE 10-QGrace Therapeutics, Inc.GRCELIVE SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE Ownership stake disclosure by Orin Hirschman (amended)
Orin Hirschman, filed by
8-KGrace Therapeutics, Inc.GRCELIVE 4Grace Therapeutics, Inc.GRCELIVE 4 insider filings
George Kottayil, insider filing for GRCE
Show all 4
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
- 4Insider filing for GRCE
George Kottayil, reporting
SCHEDULE 13G/AGrace Therapeutics, Inc.GRCELIVE ADAR1 Capital Management, LLC filed a Schedule 13G/A disclosing its 5.1% ownership stake in Grace Therapeutics, Inc. (GRCE), a biopharmaceutical company.
ADAR1 Capital Management, LLC, filed by
8-KGrace Therapeutics, Inc.GRCELIVE 10-QGrace Therapeutics, Inc.GRCELIVE